Abbott (ABT) Reports In-Line Q4 EPS; offers guidance
Get Alerts ABT Hot Sheet
Price: $90.21 +2.71%
EPS Growth %: +1.6%
Financial Fact:
Cost of products sold: 2.29B
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: +1.6%
Financial Fact:
Cost of products sold: 2.29B
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Abbott (NYSE: ABT) reported Q4 EPS of $1.34, in-line with the analyst estimate of $1.34. Revenue for the quarter came in at $10.97 billion versus the consensus estimate of $11.03 billion.
GUIDANCE:
Abbott sees FY2025 EPS of $5.05-$5.25, versus the consensus of $5.16.
Abbott projects full-year 2025 organic sales growth to be in the range of 7.5% to 8.5%.
Abbott projects full-year 2025 adjusted operating margin to be 23.5% to 24.0% of sales.
For earnings history and earnings-related data on Abbott (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump on Iran: we're trying to work out a deal that's fair
- Ross Stores (ROST) call put ratio 1 call to 1 put as share price down 3%
- Popular stocks with increasing option volume: SPCX MU INTC NFLX PLTR SOFI MSTR AMC IBM SMCI HOOD
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share